Risk of smallpox, vaccin, biowarfare;Risque de variole, vaccination et bioterrorisme

Presse Medicale

Volumn 34, Issue 2 II, 2005, Pages 177-184

  Bossi, Philippe ^a   Garin, D ^a   Combadiere B ^a   Rouleau, E ^a   Rigaudeau, S ^a   Lebrun Vignes, B ^a   Martinez, V ^a   Autran, B ^a   Bricaire, F ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE; SMALLPOX VACCINE;

BACTERIAL INFECTION; BIOLOGICAL WARFARE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; ECZEMA; EDEMA; ERADICATION THERAPY; ERYTHEMA; FRANCE; HUMAN; INJECTION PAIN; KERATITIS; LYMPHADENOPATHY; NONHUMAN; PERICARDITIS; POSTVACCINAL ENCEPHALITIS; REVIEW; SIDE EFFECT; SMALLPOX; SMALLPOX VIRUS; SUPERINFECTION; VACCINATION REACTION; VACCINIA; VIRUS STRAIN;

EID: 13244279422     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(05)83899-0     Document Type: Review

References (23)

1. WHO. Declaration of global eradication of smallpox. Wkly Epidemiol Rec 1980; 55: 148.
2. Arita L. Virological evidence for the success of the smallpox eradication programme. Nature 1979; 279: 293-8.
3. Report of the investigation into the cause of the 1978 Birmingham smallpox occurrence. London, England: Her Majesty's Stationery Office; 1980.
4. Mafart B, Le Camus JL, Merouze M, Matton T. Les dernières épidémies de variole en France. Semaine des Hôpitaux de Paris 1999; 33-34: 1265-8.
5. Breman J, Henderson D. Diagnosis and management of smallpox. N Engl J Med 2002; 346: 1300-8.
6. Henderson D, Inglesby T, Bartlett J et al. Smallpox as a biological weapon. Consensus statement. JAMA 1999; 281: 2127-37.
7. Wollenberg A, Engler R. Smallpox, vaccination and adverse reactions to smallpox vaccine. Curr Opin Allergy Clin Immunol 2004; 4: 271-5.
8. Frey S, Newman F, Cruz J et al. Dose-related effects of smallpox vaccine. N Engl J Med 2002; 346: 1275-80.
9. Frey S, Couch R, Tacket C et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med 2002; 346: 1265-74.
10. McCurdy L, Larkin B, Martin J, Graham B. Modified vaccinia Ankara: potential as an alternative smallpox vaccine. Clin Infect Dis 2004; 38: 1749-53.
11. Bartlett J, Borio L, Radonovich L et al. Smallpox vaccination in 2003: key information for clinicians. Clin Infect Dis 2003; 36: 883-902.
12. Smallpox vaccination. http://www.bt.cdc.gov/training/smallpoxvaccine/ reactions/adverse.html
13. Vaccinia immune globulin. http://www.bt.cdc.gov/training/smallpoxvaccine/ reactions/vig.html
14. Greenberg R, Schosser R, Plummer E et al. Urticaria, exanthems, and other benign dermatologic reactions to smallpox vaccination in adults. Clin Infect Dis 2004; 38: 958-65.
15. Smallpox vaccine adverse events among civilians-United States. MMWR Weekly 2003; 52: 201-3.
16. Thorpe L, Mostashari F, Karpati M et al. Mass smallpox vaccination and cardiac deaths, New York City, 1947. Emerg Infect Dis 2004; 10: 917-20.
17. Cardiac adverse events following smallpox vaccination - United States, 2003. MMWR Weekly 2003; 52: 248-50.
18. Lévy-Bruhl D, Guérin N. Utilisation du virus de la variole comme arme biologique: place de la vaccination en France. Eurosurveillance 2001; 6: 171-8.
19. Reed K, Melski J, Graham M et al. The detection of monkeypox in humans in the Western Hemisphere. N Engl J Med 2004; 350: 342-50.
20. Plan national de réponse àune menace de variole. DGS. http://www.infectiologie.com/public/documents/officiels/bt/plan-variole-dgs03. htm
21. Bricaire F, Bossi P. Plans de vaccination antivariolique en France. Med Mal Infect 2004; 34: 1-5.
22. Garin D, Crance JM, Fuchs F, Autran B, Drillien R. Actualités sur la vaccination antivariolique. Med Mal Infect 2004; 34: 20-7.
23. Combadiere B, Boissonnas A, Carcelain G et al. Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans. J Exp Med 2004; 199: 1585-93.